The publisher, authors, editors, syndication partners, and all distribution platforms make no warranties or representations regarding the completeness, accuracy, or reliability of the information and expressly disclaim any and all liability for any losses, damages, or harm resulting from the use or misuse of any product referenced in this content
Gastrointestinal adverse events including nausea and vomiting were the most common side effects but were generally transient and mild to moderate in severity
The microinfusion delivery quantities are well below systemic concern
Combining both peptides Some formulations include both AHK-Cu and GHK-Cu, attempting to capture benefits from each
Exposure to toxins, chemicals, or heavy metals may also disrupt immune tolerance